LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

BACKGROUND: Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may sometimes cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Magno, S., Ceccarini, G., Pelosini, C., Jaccheri, R., Vitti, J., Fierabracci, P., Salvetti, G., Airoldi, G., Minale, M., Saponati, G., Santini, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968477/
https://www.ncbi.nlm.nih.gov/pubmed/29793488
http://dx.doi.org/10.1186/s12944-018-0775-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968477/
https://www.ncbi.nlm.nih.gov/pubmed/29793488
http://dx.doi.org/10.1186/s12944-018-0775-8

Ejemplares similares